Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Shanghai Haoyuan Chemexpress Co's EV-to-FCF or its related term are showing as below:
SHSE:688131'
s EV-to-FCF Range Over the Past 10 Years
Min: -16051.67 Med: -13.72 Max: 851.17
Current: 75.09
During the past 13 years, the highest EV-to-FCF of Shanghai Haoyuan Chemexpress Co was 851.17. The lowest was -16051.67. And the median was -13.72.
SHSE:688131's EV-to-FCF is ranked worse than 81.83% of 567
companies
in the Drug Manufacturers industry
Industry Median: 21.08
vs SHSE:688131: 75.09
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shanghai Haoyuan Chemexpress Co (SHSE:688131) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shanghai Haoyuan Chemexpress Co's PE Ratio (TTM) for today is calculated as:
Shanghai Haoyuan Chemexpress Co's share price for today is ¥70.55.
Shanghai Haoyuan Chemexpress Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.150.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Shanghai Haoyuan Chemexpress Co EV-to-FCF Related Terms
Shanghai Haoyuan Chemexpress Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Haoyuan Chemexpress Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Haoyuan Chemexpress Co EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shanghai Haoyuan Chemexpress Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Shanghai Haoyuan Chemexpress Co's EV-to-FCF falls into.
Shanghai Haoyuan Chemexpress Co's current Enterprise Value is ¥16,183 Mil.
Shanghai Haoyuan Chemexpress Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥216 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Haoyuan Chemexpress Co (SHSE:688131) has a EV-to-FCF of 75.09 as of Jul. 22, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shanghai Haoyuan Chemexpress Co and its competitors. According to the industry distribution chart, Shanghai Haoyuan Chemexpress Co ranks #464 out of 567 companies in the Drug Manufacturers industry, placing it in the top 81.8%.
Is Shanghai Haoyuan Chemexpress Co's EV-to-FCF too high?
Shanghai Haoyuan Chemexpress Co's current EV-to-FCF is 75.09. The Drug Manufacturers industry median EV-to-FCF is 21.08. Shanghai Haoyuan Chemexpress Co's value of 75.09 is 256.2% above this industry median. Based on the distribution chart, Shanghai Haoyuan Chemexpress Co ranks #464 out of 567 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Shanghai Haoyuan Chemexpress Co has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Haoyuan Chemexpress Co's EV-to-FCF compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Shanghai Haoyuan Chemexpress Co ranks #464 out of 567 companies for EV-to-FCF. This places Shanghai Haoyuan Chemexpress Co in the lower half of its industry. The industry median EV-to-FCF is 21.08. Shanghai Haoyuan Chemexpress Co's value of 75.09 is 256.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 21.08, based on 567 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Haoyuan Chemexpress Co's current EV-to-FCF of 75.09 is 256.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shanghai Haoyuan Chemexpress Co and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 21.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Haoyuan Chemexpress Co's current EV-to-FCF is 75.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Haoyuan Chemexpress Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Haoyuan Chemexpress Co (SHSE:688131) is currently considered Fairly Valued. The stock's GF Value™ is ¥65.89, compared to a current price of ¥70.55 — trading 7.1% above its estimated fair value. The current EV-to-FCF is 75.09 and 256.2% above the Drug Manufacturers industry median of 21.08. Shanghai Haoyuan Chemexpress Co's overall GF Score™ is 92/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Shanghai Haoyuan Chemexpress Co (SHSE:688131), the current EV-to-FCF is 75.09 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Haoyuan Chemexpress Co (SHSE:688131) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Haoyuan Chemexpress Co stock appears to be overvalued.
The current stock price of ¥70.55 is trading 7.1% above its estimated GF Value™ of ¥65.89.
GuruFocus considers Shanghai Haoyuan Chemexpress Co to be Fairly Valued.
Key valuation signals for SHSE:688131:
EV-to-FCF: 75.09
GF Value™: ¥65.89 vs. price of ¥70.55 (7.1% above fair value)
Industry Position: 256.2% above the Drug Manufacturers median (#464 of 567)
No single metric tells the full story. See the SHSE:688131 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Haoyuan Chemexpress Co Business Description
Shanghai Haoyuan Chemexpress Co Ltd focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. The company's comprehensive CRO & CDMO platform is engaged in the research and development, manufacturing and supply of regulatory starting materials, novel building blocks, intermediates, reference compounds, APIs and drug products. It is a one-stop service platform to support client's projects from early drug discovery, process development to commercialization. The company is committed to delivering high-quality products and CMC services to clients across the entire life cycle of drug development.
92GF Score
Get the complete analysis for SHSE:688131
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688131 has been successfully added to your 
